Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical and Biomedical Analysis|July 5, 2011
Three spectroscopic techniques evaluated as a tool to study the effects of iodination of monoclonal antibodies, exemplified by rituximabLy Tran, Joke Baars, Carola Damen, et al.
Frontiers in Oncology|October 3, 2022
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?Alaa Embaby, Lisanne van Merendonk, Neeltje Steeghs, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 23, 2012
Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxelJohannes Moes, Stijn Koolen, Alwin Huitema, et al.
Clinical and Translational Science|November 24, 2022
A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimensLisa van der Heijden, Merel van Nuland, Jos Beijnen, et al.
Obesity Surgery|August 18, 2023
Impact of Bariatric Surgery in the Short and Long Term: A Need for Time-Dependent Dosing of DrugsCedric Lau, Charlotte van Kesteren, Robert Smeenk, et al.
Journal of Cell Communication and Signaling|May 13, 2017
Tamoxifen for induction of Cre-recombination may confound fibrosis studies in female miceLucas L Falke, Roel Broekhuizen, Alwin Huitema, et al.
Cancer Treatment Reviews|March 9, 2023
Clinical development of WEE1 inhibitors in gynecological cancers: A systematic reviewTim Schutte, Alaa Embaby, Neeltje Steeghs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Coadministration of ritonavir strongly enhances the apparent oral bioavailability of docetaxel in patients with solid tumorsRoos L Oostendorp, Alwin Huitema, Hilde Rosing, et al.
British Journal of Clinical Pharmacology|February 4, 2012
Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokineticsElin Svensson, Jan-Stefan van der Walt, Karen I Barnes, et al.
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
Pageof 2